| Financial Year |
March 31 2023 |
| Monetary Funds |
222,273,115.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
442,394,981.11 |
| Advances to Suppliers |
445,827,086.94 |
| Other Receivables |
784,756,418.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,009,289.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
211,319,017.45 |
| Total Current Assets |
2,278,579,907.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
761,985,619.15 |
| Investment Properties |
-- |
| Fixed Assetes |
2,075,782,334.24 |
| Under-construction Projects |
1,369,740,158.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,493,815.68 |
| R&D expenses |
-- |
| Goodwill |
19,722,811.84 |
| Long-Term Deferred and Prepaid Expenses |
38,217,270.38 |
| Deferred Income Tax Assets |
219,726,423.84 |
| Other Non-Current Assets |
86,717,612.71 |
| Sub-Total of Non-Current Assets |
5,076,475,528.66 |
| Total Assets |
7,355,055,436.40 |
| Short-Term Loans |
233,987,997.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,000.00 |
| Accounts Payable |
605,882,691.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
125,972,889.68 |
| Taxes Payable |
70,369,431.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,224,430,411.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
122,006,001.33 |
| Other Current Liabilities |
414,662,145.95 |
| Sub-Total of Current Liabilities |
3,251,467,381.63 |
| Long-term Loans |
-- |
| Bonds Payable |
2,004,949,349.58 |
| Long-Term Accounts Payable |
120,626,612.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
22,041,695.23 |
| Deferred Income Tax Liabilities |
41,325,401.76 |
| Other Non-Current Liabilities |
928,559,620.67 |
| Sub-Total of Non-Current Liabilities |
3,150,609,433.49 |
| Total Liabilities |
6,402,076,815.12 |
| Paid-In Capital(Or Share Stock) |
1,657,463,906.00 |
| Capital Surplus |
3,473,916,937.18 |
| Surplus Reserve |
390,686,491.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,195,080,852.25 |
| Minority Stockholder's Interest |
-150,289,123.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,103,267,744.37 |
| Owner's Equity（Stockholder's Equity） |
952,978,621.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,355,055,436.40 |
